Compare
Abbott Laboratories vs Intuitive Surgical (ABT vs ISRG)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Intuitive Surgical (ISRG) -17.5%; so far this year the figures are -12.3% and -20.1%.
Abbott Laboratories is the larger company by market value, about 1.2 times the size of Intuitive Surgical.
On trailing earnings, ABT trades at 40.9 times and ISRG at 54.8 times.
Revenue grew +10.0% at ABT and +20.5% at ISRG over the last year.
ABT yields 2.29%. ISRG pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | ISRG | |
|---|---|---|
| Price | $109.93 | $452.80 |
| 1-day | -3.23% | -3.36% |
| YTD | -12.26% | -20.05% |
| 1 year | -11.73% | -17.46% |
| 3 years | +15.70% | +67.42% |
| Market cap | $190.4B | $157.0B |
| P/E | 40.9 | 54.8 |
| P/S | 3.95 | 13.56 |
| P/B | 3.73 | 9.82 |
| Revenue growth | +10.00% | +20.50% |
| EPS growth | -66.20% | +9.10% |
| Gross margin % | 56.9 | 67.2 |
| Net margin % | 9.7 | 25.5 |
| ROE % | 9.2 | 18.5 |
| Debt / equity | 0.61 | 0.00 |
| FCF yield % | 3.5 | 2.3 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.92 |
| RSI (14) | 58.5 | 57.2 |
| Technical rating |